Eastman Chemical Co (EMN) Stock: Tracking the Weekly Performance

Biotech Stocks to buy

The stock of Eastman Chemical Co (EMN) has seen a -6.60% decrease in the past week, with a -10.13% drop in the past month, and a -9.53% decrease in the past quarter. The volatility ratio for the week is 3.99%, and the volatility levels for the past 30 days are at 2.79% for EMN. The simple moving average for the last 20 days is -7.25% for EMN’s stock, with a simple moving average of -9.25% for the last 200 days.

Is It Worth Investing in Eastman Chemical Co (NYSE: EMN) Right Now?

Eastman Chemical Co (NYSE: EMN) has a higher price-to-earnings ratio of 11.78x compared to its average ratio, The 36-month beta value for EMN is at 1.38. Analysts have varying views on the stock, with 8 analysts rating it as a “buy,” 3 rating it as “overweight,” 9 as “hold,” and 0 as “sell.”

The public float for EMN is 114.31M, and currently, shorts hold a 2.53% of that float. The average trading volume for EMN on March 14, 2025 was 1.09M shares.

EMN) stock’s latest price update

Eastman Chemical Co (NYSE: EMN)’s stock price has dropped by -2.02 in relation to previous closing price of 92.41. Nevertheless, the company has seen a loss of -6.60% in its stock price over the last five trading days. businesswire.com reported 2025-03-04 that KINGSPORT, Tenn.–(BUSINESS WIRE)–Eastman CFO Willie McLain will address the J.P. Morgan Industrials Conference on March 11, 2025, at 11:15 a.m. ET.

Analysts’ Opinion of EMN

Many brokerage firms have already submitted their reports for EMN stocks, with BofA Securities repeating the rating for EMN by listing it as a “Buy.” The predicted price for EMN in the upcoming period, according to BofA Securities is $109 based on the research report published on January 14, 2025 of the current year 2025.

Citigroup, on the other hand, stated in their research note that they expect to see EMN reach a price target of $104, previously predicting the price at $118. The rating they have provided for EMN stocks is “Neutral” according to the report published on December 18th, 2024.

Wells Fargo gave a rating of “Overweight” to EMN, setting the target price at $125 in the report published on November 26th of the previous year.

EMN Trading at -5.11% from the 50-Day Moving Average

After a stumble in the market that brought EMN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -20.93% of loss for the given period.

Volatility was left at 2.79%, however, over the last 30 days, the volatility rate increased by 3.99%, as shares sank -10.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.31% lower at present.

During the last 5 trading sessions, EMN fell by -6.60%, which changed the moving average for the period of 200-days by -8.59% in comparison to the 20-day moving average, which settled at $97.61. In addition, Eastman Chemical Co saw -0.85% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at EMN starting from Caveness Michelle H, who sale 1,147 shares at the price of $98.51 back on Mar 03 ’25. After this action, Caveness Michelle H now owns 1,167 shares of Eastman Chemical Co, valued at $112,991 using the latest closing price.

Caveness Michelle H, the Officer of Eastman Chemical Co, proposed sale 1,147 shares at $98.51 during a trade that took place back on Mar 03 ’25, which means that Caveness Michelle H is holding shares at $112,991 based on the most recent closing price.

Stock Fundamentals for EMN

Current profitability levels for the company are sitting at:

  • 0.11 for the present operating margin
  • 0.25 for the gross margin

The net margin for Eastman Chemical Co stands at 0.1. The total capital return value is set at 0.08. Equity return is now at value 16.11, with 6.06 for asset returns.

Based on Eastman Chemical Co (EMN), the company’s capital structure generated 0.46 points at debt to capital in total, while cash flow to debt ratio is standing at 0.26. The debt to equity ratio resting at 0.87. The interest coverage ratio of the stock is 4.7.

Currently, EBITDA for the company is 1.8 billion with net debt to EBITDA at 2.26. When we switch over and look at the enterprise to sales, we see a ratio of 1.56. The receivables turnover for the company is 8.0for trailing twelve months and the total asset turnover is 0.62. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.51.

Conclusion

In conclusion, Eastman Chemical Co (EMN) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts